Orabi Hajjeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Orabi Hajjeh has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Adam Andrew Dmytriw
Nuffield Department of Surgical Sciences, Medical Sciences Division, University of Oxford, Oxford, United Kingdom
3 shared publications - Dhairya A. Lakhani
Department of Neuroradiology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown (D.A.L.).
3 shared publications - Hamza Adel Salim
Department of Neuroradiology, MD Anderson Cancer Center, Houston, TX (H.A.S.).
3 shared publications Dheeraj Gandhi
Division of Neurointerventional Surgery, Department of Neurosurgery, University of Maryland Medical Center, Baltimore, Md
2 shared publications- Huanwen Chen
Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
2 shared publications - Jens Fiehler
Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (J.F.).
2 shared publications
Latest Publications
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (9) , 2744-2753
MAD-MT Score: A Tool to Optimize Patient Selection for Mechanical Thrombectomy in Distal Vessel Occlusions
BACKGROUND: Endovascular thrombectomy (EVT) for distal and medium vessel occlusion stroke remains uncertain. We aimed to develop a medium and distal mechanical thrombectomy score integrating clinical need and procedural risk to guide patient selection. METHODS: This retrospective cohort analysis used an international distal and medium vessel occlusion stroke registry spanning the study period of 2017 to 2023. Patients with acute distal and medium vessel occlusion stroke who received medical management (MM) or EVT across 37 stroke centers were included, and those with baseline modified Rankin Scale score of ≥3 or those with missing covariable data were excluded. Multivariable logistic regression identified predictors of poor functional outcome (modified Rankin Scale score >2 at 90 days) in the MM cohort and predictors of EVT failure/complications in the EVT cohort. Predictors of poor outcome on MM were assigned positive weights (clinical need); predictors of EVT failure/harm were assigned negative weights (procedural risk). The medium and distal mechanical thrombectomy score summed these weighted points. Interaction analysis assessed the heterogeneity of EVT effect by score. RESULTS: A total of 1217 patients were identified, and 1007 were included (EVT: 822, MM: 185; median age 73 years; 41% female). Higher National Institutes of Health Stroke Scale score (+1 per point) and lack of intravenous thrombolysis (+7) predicted poor MM outcomes. In the EVT cohort, older age (−1 per 15 years above 25), absence of hypertension (−2), and absence of atrial fibrillation (−2) predicted failure/complications. The medium and distal mechanical thrombectomy score (range −8 to 49) significantly modified EVT effect versus MM ( P interaction =0.048). In high-score patients (≥15; n=293), EVT yielded a better 90-day modified Rankin Scale score than MM (median, 3 versus 4; P =0.009). Conversely, in low-score patients (P =0.014). CONCLUSIONS: The medium and distal mechanical thrombectomy score is a pragmatic tool that identifies patients with distal and medium vessel occlusion most likely to benefit from EVT while minimizing risk, supporting patient-centered decisions and future trial design.
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (9) , 2744-2753
MAD-MT Score: A Tool to Optimize Patient Selection for Mechanical Thrombectomy in Distal Vessel Occlusions
BACKGROUND: Endovascular thrombectomy (EVT) for distal and medium vessel occlusion stroke remains uncertain. We aimed to develop a medium and distal mechanical thrombectomy score integrating clinical need and procedural risk to guide patient selection. METHODS: This retrospective cohort analysis used an international distal and medium vessel occlusion stroke registry spanning the study period of 2017 to 2023. Patients with acute distal and medium vessel occlusion stroke who received medical management (MM) or EVT across 37 stroke centers were included, and those with baseline modified Rankin Scale score of ≥3 or those with missing covariable data were excluded. Multivariable logistic regression identified predictors of poor functional outcome (modified Rankin Scale score >2 at 90 days) in the MM cohort and predictors of EVT failure/complications in the EVT cohort. Predictors of poor outcome on MM were assigned positive weights (clinical need); predictors of EVT failure/harm were assigned negative weights (procedural risk). The medium and distal mechanical thrombectomy score summed these weighted points. Interaction analysis assessed the heterogeneity of EVT effect by score. RESULTS: A total of 1217 patients were identified, and 1007 were included (EVT: 822, MM: 185; median age 73 years; 41% female). Higher National Institutes of Health Stroke Scale score (+1 per point) and lack of intravenous thrombolysis (+7) predicted poor MM outcomes. In the EVT cohort, older age (−1 per 15 years above 25), absence of hypertension (−2), and absence of atrial fibrillation (−2) predicted failure/complications. The medium and distal mechanical thrombectomy score (range −8 to 49) significantly modified EVT effect versus MM ( P interaction =0.048). In high-score patients (≥15; n=293), EVT yielded a better 90-day modified Rankin Scale score than MM (median, 3 versus 4; P =0.009). Conversely, in low-score patients (P =0.014). CONCLUSIONS: The medium and distal mechanical thrombectomy score is a pragmatic tool that identifies patients with distal and medium vessel occlusion most likely to benefit from EVT while minimizing risk, supporting patient-centered decisions and future trial design.
- Open Access
- 26 August 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (9) , e73407
HHV‐6–Positive Meningitis in an Immunocompetent Adult: Diagnostic Challenges in Distinguishing Active Infection From Chromosomal Integration: A Case Report
Consider human herpesvirus 6 (HHV‐6) in immunocompetent adults with viral meningitis when standard tests are negative. Qualitative CSF PCR requires cautious interpretation because it cannot exclude chromosomally integrated HHV‐6. Serial CSF improvement and rapid clinical recovery may support probable self‐limited infection and help avoid unnecessary ganciclovir or foscarnet therapy.
- 26 August 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (9) , e73407
Open AccessHHV‐6–Positive Meningitis in an Immunocompetent Adult: Diagnostic Challenges in Distinguishing Active Infection From Chromosomal Integration: A Case Report
Consider human herpesvirus 6 (HHV‐6) in immunocompetent adults with viral meningitis when standard tests are negative. Qualitative CSF PCR requires cautious interpretation because it cannot exclude chromosomally integrated HHV‐6. Serial CSF improvement and rapid clinical recovery may support probable self‐limited infection and help avoid unnecessary ganciclovir or foscarnet therapy.
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (3) , e252487
Ischemic Lesion Net Water Uptake Outperforms ASPECTS and CBF Less Than 30% in Predicting Futile Recanalization after Mechanical Thrombectomy
Admission CT–measured net water uptake predicted futile recanalization after successful endovascular thrombectomy in patients with large vessel stroke, outperforming ischemic core volume and Alberta Stroke Program Early CT Score.
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (3) , e252487
Ischemic Lesion Net Water Uptake Outperforms ASPECTS and CBF Less Than 30% in Predicting Futile Recanalization after Mechanical Thrombectomy
Admission CT–measured net water uptake predicted futile recanalization after successful endovascular thrombectomy in patients with large vessel stroke, outperforming ischemic core volume and Alberta Stroke Program Early CT Score.
- Open Access
- 2 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
Preoperative middle meningeal artery embolization is associated with reduced reoperation rates in chronic subdural hematoma
Background: Middle meningeal artery embolization (MMAE) has recently emerged as a promising adjunctive therapy to surgical evacuation for patients with chronic subdural hematoma (cSDH). However, the optimal timing of MMAE relative to surgery remains poorly defined. Therefore, this large retrospective cohort study aimed to assess the impact of MMAE timing (preoperative vs. postoperative) on 6-month outcomes in patients with cSDH, focusing on rates of repeat surgery and mortality. We hypothesized that preoperative MMAE would be associated with lower rates of reoperation compared to postoperative MMAE. Methods: Adult patients with nontraumatic cSDH who underwent surgery with adjunctive MMAE were identified using ICD-10 codes from the TriNetX database. A 1:1 propensity score matching approach was used to balance baseline characteristics between groups. The primary outcomes were repeat surgery and all-cause mortality within 6 months. Results: A total of 338 matched patients ( n = 338; 169 in each group) were included in the final analysis. Preoperative MMAE was associated with significantly lower odds of repeat surgery compared to postoperative MMAE (7.1% vs. 17.8%; OR 0.35, p = 0.003). No significant difference was observed in 6-month all-cause mortality between the groups. Conclusion: Preoperative MMAE is associated with reduced odds of repeat surgery compared to postoperative MMAE at 6 months. These findings support consideration of MMAE timing in surgical planning. Further prospective studies are warranted to validate these results.
- 2 September 2025
- Published by SAGE Publications in Interventional Neuroradiology
Open AccessPreoperative middle meningeal artery embolization is associated with reduced reoperation rates in chronic subdural hematoma
Background: Middle meningeal artery embolization (MMAE) has recently emerged as a promising adjunctive therapy to surgical evacuation for patients with chronic subdural hematoma (cSDH). However, the optimal timing of MMAE relative to surgery remains poorly defined. Therefore, this large retrospective cohort study aimed to assess the impact of MMAE timing (preoperative vs. postoperative) on 6-month outcomes in patients with cSDH, focusing on rates of repeat surgery and mortality. We hypothesized that preoperative MMAE would be associated with lower rates of reoperation compared to postoperative MMAE. Methods: Adult patients with nontraumatic cSDH who underwent surgery with adjunctive MMAE were identified using ICD-10 codes from the TriNetX database. A 1:1 propensity score matching approach was used to balance baseline characteristics between groups. The primary outcomes were repeat surgery and all-cause mortality within 6 months. Results: A total of 338 matched patients ( n = 338; 169 in each group) were included in the final analysis. Preoperative MMAE was associated with significantly lower odds of repeat surgery compared to postoperative MMAE (7.1% vs. 17.8%; OR 0.35, p = 0.003). No significant difference was observed in 6-month all-cause mortality between the groups. Conclusion: Preoperative MMAE is associated with reduced odds of repeat surgery compared to postoperative MMAE at 6 months. These findings support consideration of MMAE timing in surgical planning. Further prospective studies are warranted to validate these results.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2025 (1)
Neonatal Brucellosis in an Extremely Preterm Infant: A Fatal Case Report
Background: Brucellosis is a globally significant zoonotic disease, but congenital brucellosis remains exceedingly rare. It is primarily transmitted transplacentally from an infected mother to the fetus, often presenting with nonspecific signs that mimic neonatal sepsis. The condition poses diagnostic and therapeutic challenges, particularly in endemic regions where early identification is crucial to improving neonatal outcomes. Case Presentation: We report the case of a 19‐year‐old gravida 1, para 0 female with a history of treated Brucella infection at 12 weeks of gestation. She experienced preterm premature rupture of membranes (PPROM) at 24 weeks and 2 days and delivered a female infant via spontaneous vaginal delivery. The neonate, weighing 725 g at birth, presented with cyanosis, respiratory distress, and unstable vital signs. Initial workup suggested early onset sepsis, prompting empirical antibiotic therapy. However, on Day 7, blood cultures confirmed the presence of Brucella melitensis and Brucella abortus , establishing the diagnosis of congenital brucellosis. The neonate’s clinical course was complicated by intraventricular hemorrhage, necrotizing enterocolitis, multiple episodes of sepsis, and cardiac arrests. Despite intensive medical management, including antimicrobial therapy with rifampicin and gentamicin, the infant succumbed to multiple organ failure on Day 39 of life. Conclusion: This case highlights the diagnostic challenges of congenital brucellosis and underscores the importance of considering Brucella infection in neonates presenting with unexplained sepsis, especially in endemic regions. Early recognition and targeted therapy are essential to improve neonatal outcomes. Enhanced screening protocols for pregnant women in high‐risk areas, coupled with heightened clinical suspicion in neonates with maternal brucellosis exposure, could facilitate timely diagnosis and treatment.
- 1 January 2025
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2025 (1)
Open AccessNeonatal Brucellosis in an Extremely Preterm Infant: A Fatal Case Report
Background: Brucellosis is a globally significant zoonotic disease, but congenital brucellosis remains exceedingly rare. It is primarily transmitted transplacentally from an infected mother to the fetus, often presenting with nonspecific signs that mimic neonatal sepsis. The condition poses diagnostic and therapeutic challenges, particularly in endemic regions where early identification is crucial to improving neonatal outcomes. Case Presentation: We report the case of a 19‐year‐old gravida 1, para 0 female with a history of treated Brucella infection at 12 weeks of gestation. She experienced preterm premature rupture of membranes (PPROM) at 24 weeks and 2 days and delivered a female infant via spontaneous vaginal delivery. The neonate, weighing 725 g at birth, presented with cyanosis, respiratory distress, and unstable vital signs. Initial workup suggested early onset sepsis, prompting empirical antibiotic therapy. However, on Day 7, blood cultures confirmed the presence of Brucella melitensis and Brucella abortus , establishing the diagnosis of congenital brucellosis. The neonate’s clinical course was complicated by intraventricular hemorrhage, necrotizing enterocolitis, multiple episodes of sepsis, and cardiac arrests. Despite intensive medical management, including antimicrobial therapy with rifampicin and gentamicin, the infant succumbed to multiple organ failure on Day 39 of life. Conclusion: This case highlights the diagnostic challenges of congenital brucellosis and underscores the importance of considering Brucella infection in neonates presenting with unexplained sepsis, especially in endemic regions. Early recognition and targeted therapy are essential to improve neonatal outcomes. Enhanced screening protocols for pregnant women in high‐risk areas, coupled with heightened clinical suspicion in neonates with maternal brucellosis exposure, could facilitate timely diagnosis and treatment.